The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system
Open accessAbstract
Lactic acidosis is a serious, metabolic complication that may occur due to metformin hydrochloride (MH) accumulation during the treatment of diabetes mellitus. The aim of this study is to enhance the bioavailability of MH by oral route. Span 40 and cholesterol were used for the preparation of MH-loaded niosomes by the reverse phase evaporation technique. Dicetyl phosphate (DCP) and 1,2-dioleoyl-3-trimethylammonium-propane chloride salt (DOTAP) were used to obtain negatively and positively charged vesicles, respectively. The mean particle size ranged from 223.5 to 384.6 nm and the MH-loaded niosomes' surface was negatively charged in the absence of charge inducing agents (-16.6 ± 1.4 mV) and also with DCP (-26.9 ± 1.0 mV), while it was positively charged (+8.7 ± 1.2 mV) with DOTAP. High entrapment efficiency was observed in all the formulations. MH-loaded niosomes were found to effectively sustain the release of drug, particularly with positively charged niosomes. The bioavailability of MH-loaded niosomes was assessed by measuring the serum values of glucose and metformin in the different studied Wistar rats groups. The pharmacokinetic data of MH-loaded niosomal preparation showed a significant prolongation and increased intensity of hypoglycemic effect more than that observed for free MH solution. Area above the blood glucose levels-time curve (AAC), maximum hypoglycemic response and time of maximum response (T(max)) were significantly higher (p < 0.001) when MH was administered in niosomal form compared to free drug solution. It could be concluded that MH-loaded niosome is promising extended-release preparation with better hypoglycemic efficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Pharmacokinetic testing confirmed the better efficacy of metformin-loaded niosomes over pure metformin in reducing blood glucose levels.84”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor
Trinder, P. (1969) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456326900600108 · Cited by 4,629
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Papahadjopoulos, D., Jacobson, K., Nir, S., & Isac, I. (1973) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(73)90314-3 · Cited by 998
Ladbrooke, B. D., Williams, R. M., & Chapman, D. (1968) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(68)90132-6 · Cited by 890
Clinical Pharmacokinetics of Metformin
Scheen, A. J. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630050-00003 · Cited by 649
Niosome: A future of targeted drug delivery systems
Kuotsu, K., Karim, K. M., Mandal, A. S., Biswas, N., Guha, A., Chatterjee, S., & Behera, M. (2010) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/0110-5558.76435 · Cited by 627
YOSHIOKA, T., Sternberg, B., & Florence, A. T. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90228-3 · Cited by 476
Research works printed but not linked: 5
- Akhilesh D, Anoop VN, Rao BP. (2011). Formulation and evaluation of gliclazide loaded maltodextrin based proniosomes. Int J Res Pharm Biomed Sci 2:1582–9
- Finkelstein MC, Weissman G. (1979). Enzyme replacement via liposomes. Int J Pharm 588:202–16
- Khandare JN, Madhavi G, Tamhankar BM. (1994). Niosomes novel drug delivery system. East Pharm 37:61–4
- 10.1080/026520499288672 · DOI
- Raja Naresh RA, Chandrashekhar G, Pillai GK, Udupa N. (1994). Anti-inflammatory activity of niosome encapsulated diclofenac sodium with Tween-85 in Arthitic rats. Indian J Pharmacol 26:46–8
Cited by
Sorted by citations
Type II diabetes mellitus: a review on recent drug based therapeutics.
Padhi, S., Nayak, A. K., & Behera, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110708 · Cited by 726
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645
Nanoparticle Delivery Systems in the Treatment of Diabetes Complications
Souto, E. B., Souto, S. B., Campos, J. R. S., Severino, P. B., Pashirova, T. N., Zakharova, L. Y., Silva, A. M., Durazzo, A., Lucarini, M., Izzo, A. A., et al. (2019) · Molecules · doi:10.3390/molecules24234209 · Cited by 254
Nanotechnology based approaches for anti-diabetic drugs delivery
Kesharwani, P., Gorain, B., Low, S. Y., Tan, S. A., Ling, E. C. S., Lim, Y. K., Chin, C. M., Lee, P. Y., Lee, C. M., Ooi, C. H., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.11.018 · Cited by 204
Swamy, B. Y., & Yun, Y. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.03.019 · Cited by 166
Dadashzadeh, S., Haeri, A., Daeihamed, M., Arzani, G., & Kaboutaraki, H. B. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s84703 · Cited by 126
Trends of nanotechnology in type 2 diabetes mellitus treatment
Simos, Y. V., Spyrou, K., Patila, M., Karouta, N., Stamatis, H., Gournis, D., Dounousi, E. C., & Peschos, D. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2020.05.001 · Cited by 112
Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride
Çetin, M., & Şahin, S. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1089957 · Cited by 111
Novel drug delivery system: an immense hope for diabetics
Rai, V. K., Mishra, N., Agrawal, A. K., Jain, S., & Yadav, N. P. (2014) · Drug Delivery · doi:10.3109/10717544.2014.991001 · Cited by 102
Uppal, S., Italiya, K. S., Chitkara, D., & Mittal, A. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.09.049 · Cited by 102
Lipid-Based Nanovesicular Drug Delivery Systems
Limongi, T., Susa, F., Marini, M., Allione, M., Torre, B., Pisano, R., & Fabrizio, E. M. D. (2021) · Nanomaterials · doi:10.3390/nano11123391 · Cited by 90
Shukla, S. K., Kulkarni, N. S., Chan, A., Parvathaneni, V., Farrales, P., Muth, A., & Gupta, V. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110559 · Cited by 83
Samed, N., Sharma, V., & Sundaramurthy, A. (2017) · Applied Surface Science · doi:10.1016/j.apsusc.2017.11.055 · Cited by 82
Therapeutic medications against diabetes: What we have and what we expect
Hu, C., & Jia, W. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.11.008 · Cited by 81
Niosome Preparation Techniques and Structure—An Illustrated Review
Mawazi, S. M., Ge, Y., & Widodo, R. T. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17010067 · Cited by 75
Emerging Treatment Strategies for Diabetes Mellitus and Associated Complications: An Update
Mishra, V. K., Nayak, P., Sharma, M., Albutti, A., Alwashmi, A. S. S., Aljasir, M. A., Alsowayeh, N., & Tambuwala, M. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101568 · Cited by 72
El-Nabarawi, M. A., Tag, R., Teaima, M. H. M., Abary, M. Y. S., El-Mofty, H. M., Khafagy, M. M., Lotfy, N. M., & Salah, M. (2019) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2019.1579827 · Cited by 71
Maestrelli, F., Mura, P., González-Rodrı́guez, M. L., Cózar-Bernal, M. J., Rabasco, A. M., Mannelli, L. D. C., & Ghelardini, C. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.083 · Cited by 69
Optimized Mucoadhesive Coated Niosomes as a Sustained Oral Delivery System of Famotidine
Khalifa, A.-Z. M., & Rasool, B. K. A. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0780-7 · Cited by 65
Akbarzadeh, I., Keramati, M., Azadi, A., Afzali, E., Shahbazi, R., Chiani, M., Norouzian, D., & Bakhshandeh, H. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.105019 · Cited by 65
Kulkarni, P., Rawtani, D., & Barot, T. D. (2019) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2019.01.004 · Cited by 63
Raafat, K. M., & El‐Zahaby, S. A. (2020) · Chinese Medicine · doi:10.1186/s13020-020-00321-1 · Cited by 62
Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles.
Akbari, V., Abedi, D., Pardakhty, A., & Sadeghi‐Aliabadi, H. (2015) · Europe PMC (PubMed Central) · Cited by 62
Adetunji, C. O., Michael, O. S., Rathee, S., Singh, K. R., Ajayi, O. O., Adetunji, J. B., Ojha, A., Singh, J., & Singh, R. P. (2021) · Materials Today Advances · doi:10.1016/j.mtadv.2021.100198 · Cited by 62
Sabry, S. A., Ramadan, H. E., Elghany, M. A., Okda, T. M., & Hasan, A. A. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102163 · Cited by 58
Self-citationNanomedicines for endothelial disorders
Chung, B. L., Toth, M. J., Kamaly, N., Sei, Y. J., Becraft, J. R., Mulder, W. J. M., Fayad, Z. A., Farokhzad, O. C., Kim, Y., & Langer, R. (2015) · Nano Today · doi:10.1016/j.nantod.2015.11.009 · Cited by 59
Mohsen, A. M., AbouSamra, M. M., & ElShebiney, S. A. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1310224 · Cited by 58
Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin
Imran, M. A., Shah, M. R., Ullah, F., Ullah, S., Elhissi, A. M. A., Nawaz, W., Ahmad, F., Sadiq, A., & Ali, I. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1214991 · Cited by 56
Fouad, S. A., Teaima, M. H. M., Gebril, M. I., Abd-Allah, F. I., El-Nabarawi, M. A., & Elhabal, S. F. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2181747 · Cited by 46
Metformin hydrochloride and wound healing: from nanoformulation to pharmacological evaluation
El-Ridy, M. S., Yehia, S. A., Elsayed, I., Younis, M. M., Abdel-Rahman, R. F., & El-Gamil, M. A. (2018) · Journal of Liposome Research · doi:10.1080/08982104.2018.1556291 · Cited by 45
Li, Y., Luo, J., Lin, M., Zhi, P., Guo, W.-W., Han, M. Y., You, J., & Gao, J. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00199 · Cited by 45
Lee, S., & Hassan, Y. A. (2017) · International Journal of Heat and Mass Transfer · doi:10.1016/j.ijheatmasstransfer.2017.09.047 · Cited by 43
Shukla, S. K., Nguyen, V., Goyal, M., & Gupta, V. (2022) · Nanomedicine · doi:10.2217/nnm-2022-0045 · Cited by 42
Kenechukwu, F. C., Nnamani, D. O., Duhu, J. C., Nmesirionye, B. U., Momoh, M. A., Akpa, P. A., & Attama, A. A. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09099 · Cited by 40
Saini, N., Sodhi, R. K., Bajaj, L., Pandey, R. S., Jain, U. K., Katare, O. P., & Madan, J. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.04.016 · Cited by 39
AbouSamra, M. M., Basha, M., Awad, G. E. A., & Mansy, S. S. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.12.014 · Cited by 39
Recent developments in nanoparticles for the treatment of diabetes
Sharma, D. K., Pattnaik, G., & Behera, A. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2261077 · Cited by 37
Debele, T. A., & Park, Y. C. (2022) · Life · doi:10.3390/life12122078 · Cited by 34
Malbois, P., Salaün, E., Vandel, A., Godard, G., Cabot, G., Renou, B., Boukhalfa, A. M., & Grisch, F. (2019) · Combustion and Flame · doi:10.1016/j.combustflame.2019.03.041 · Cited by 32
Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis
Luo, X., Yan, C., & Feng, Y. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.004 · Cited by 35
Liu, F., Jin, H., Wang, Y., Chen, C., Li, M., Mao, S., Wang, Q., & Li, H. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1333170 · Cited by 32
Application of Nanomaterials in the Diagnosis and Treatment of Genetic Disorders
Aljabali, A. A. A., Obeid, M. A., Amawi, H. A., Rezigue, M. M., Hamzat, Y., Satija, S., & Tambuwala, M. M. (2020) · Springer eBooks · doi:10.1007/978-981-15-4802-4_7 · Cited by 30
Arafa, K., Shamma, R. N., El-Gazayerly, O. N., & El-sherbiny, I. M. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1438463 · Cited by 29
Ullah, S., Shah, M. R., Shoaib, M., Imran, M. A., Shah, S. W. A., Ali, I., & Ahmed, F. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1291667 · Cited by 27
Nanotechnology Advanced Strategies for the Management of Diabetes Mellitus
Mohsen, A. M. (2019) · Current Drug Targets · doi:10.2174/1389450120666190307101642 · Cited by 27
Salmani-Javan, E., Jafari-Gharabaghlou, D., Bonabi, E., & Zarghami, N. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1193708 · Cited by 24
Characterization of insulin-loaded liposome using column-switching HPLC
Ohnishi, N., Tanaka, S., Tahara, K., & Takeuchi, H. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.056 · Cited by 24
Kashani-Asadi-Jafari, F., & Hadjizadeh, A. (2022) · Pharmaceutical Nanotechnology · doi:10.2174/2211738510666220224103406 · Cited by 23
Niosomal Delivery of Celecoxib and Metformin for Targeted Breast Cancer Treatment
Basheer, H. A., Alhusban, M. A., Alkilani, A. Z., Alshishani, A., Elsalem, L., & Afarinkia, K. (2023) · Cancers · doi:10.3390/cancers15205004 · Cited by 23
Raj, J., & Uppuluri, K. B. (2015) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/585 · Cited by 23
Core–shell drug carriers: liposomes, polymersomes, and niosomes
Dan, N. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00002-6 · Cited by 21
Gorosábel, A., Pedrana, J., Bernad, L., Caballero, V. J., Muñoz, S. D., & Maceira, N. (2019) · Agriculture Ecosystems & Environment · doi:10.1016/j.agee.2019.04.002 · Cited by 21
Formulation and evaluation of Metformin Hydrochloride-loaded Curcumin–Lycopene Niosomes
Katrolia, A., Chauhan, S. B., & Shukla, V. K. (2019) · SN Applied Sciences · doi:10.1007/s42452-019-1768-6 · Cited by 20
Zidan, A., Saadany, A. A. E., Maghraby, G. M. E., Abdin, A. A., & Hedya, S. E. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116448 · Cited by 20
Novel Approaches for the Management of Type 2 Diabetes Mellitus: An Update
Kumar, A., Mazumder, R., Rani, A., Pandey, P., & Khurana, N. (2023) · Current Diabetes Reviews · doi:10.2174/0115733998261903230921102620 · Cited by 21
Kulkarni, P., Rawtani, D., Rajpurohit, S., Vasvani, S., & Barot, T. D. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103627 · Cited by 19
A POD-based reduced-order model for uncertainty analyses in shallow water flows
Zokagoa, J.-M., & Soulaïmani, A. (2018) · International journal of computational fluid dynamics · doi:10.1080/10618562.2018.1513496 · Cited by 19
Verma, A., & Riaz, U. (2018) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2018.03.072 · Cited by 18
Exploring the use of niosomes in cosmetics for efficient dermal drug delivery
Abu‐Huwaij, R., Alkarawi, A., Salman, D., & Alkarawi, F. (2023) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2023.2233613 · Cited by 17
Sahu, A. K., & Verma, A. (2016) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-016-0229-0 · Cited by 17
Enhancement of the Anti-inflammatory Efficacy of Betamethasone Valerate via Niosomal Encapsulation
(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac116.1464014660 · Cited by 17
Raychaudhuri, R., Pandey, A., Hegde, A. R., Fayaz, S. M. A., Chellappan, D. K., Dua, K., & Mutalik, S. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1819237 · Cited by 15
Ossai, E. C., Madueke, C. A., Amadi, E. B., Ogugofor, M. O., Momoh, A. M., Okpala, C. O. R., Anosike, C. A., & NJOKU, O. U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062852 · Cited by 15
Bhardwaj, S., & Bhatia, S. (2020) · PubMed Central · doi:10.22037/ijpr.2020.112887.14003 · Cited by 14
Kattar, A., Concheiro, Á., & Alvarez‐Lorenzo, C. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1953466 · Cited by 14
Dan, N. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813627-0.00001-6 · Cited by 14
Biomimetic engineered nanocarriers inspired by viruses for oral-drug delivery
Zhang, J., Liu, X., Lin, J., Bao, X., Peng, J., Gong, Z., Luan, X., & Chen, Y. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121979 · Cited by 13
Kotha, A. A., Ahmad, S. U., Dewan, I., Bhuiyan, M. A., Rahman, F. I., Mohamed, I. N., & Reza, M. S. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s432790 · Cited by 12
Arshad, N., Shaheen, F., Khan, I. N., Naeem, S., Riaz, M., Siddique, M. I., Ayesha, M., & Waqar, M. A. (2024) · International Journal of Polymeric Materials · doi:10.1080/00914037.2024.2426611 · Cited by 11
Cheng, X., Xu, Y., Jia, Q., Guo, N., Wang, Z., & Wang, Y. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1809555 · Cited by 11
Key Aspects in Nanotechnology and Drug Delivery
Arias, J. L. (2014) · CRC Press eBooks · doi:10.1201/b17271-2 · Cited by 11
NIOSOMES VERSUS PRONIOSOMES AS PROMISING DRUG DELIVERY SYSTEMS IN TREATMENT OF DIABETES MELLITUS
Teaima, M. H. M., Gebril, M. I., Abd-Allah, F. I., & El-Nabarawi, M. A. (2022) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2022v14i5.44039 · Cited by 10
Sheta, N. M., El-Gazar, A. A., Ragab, G. M., Essa, M. A., Abdel-Haleem, K. M., & El-Dahmy, R. M. (2024) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2024.031 · Cited by 10
A de novo formulation of metformin using chitosan‐based nanomicelles for potential diabetes therapy
Abbasian, M., Bighlari, P., Mahmoodzadeh, F., Acar, M. H., & Jaymand, M. (2019) · Journal of Applied Polymer Science · doi:10.1002/app.48037 · Cited by 10
Younes, N. F., Latif, R., Badawi, A. A. E.-L., & Hegazy, K. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100357 · Cited by 9
Nanocarriers and Diabetes: New Vistas and the Way Ahead
Mishra, D. K., Gautam, R. K., Dixit, P. V., & Sharma, S. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201024666221227140728 · Cited by 9
Abdel-Aziz, R. T. A., Aly, U. F., & Mady, F. M. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102235 · Cited by 9
Organogel investigations as a floating oral system with depot property
Kadoori, Z. S., Mohamed, M. B. M., & Numan, N. A. M. (2022) · Al Mustansiriyah Journal of Pharmaceutical Sciences · doi:10.32947/ajps.v20i4.783 · Cited by 8
Rezvanjou, S. N., Niavand, M. R., Shayesteh, O. H., Yeganeh, E. M., Moghadam, D. A., Derakhshandeh, K., & Mahjub, R. (2023) · Journal of Microencapsulation · doi:10.1080/02652048.2023.2170488 · Cited by 8
Silybin-based herbal nanocarriers: an advancement in anticancer therapy
Shete, M. B., Deshpande, A. S., & Shende, P. K. (2022) · Materials Technology · doi:10.1080/10667857.2022.2081286 · Cited by 8
Therapeutic applications of nanomedicine in metabolic diseases by targeting the endothelium
Hou, L., Zhang, M., Liu, L., Zhong, Q., Xie, M., & Zhao, G. (2022) · QJM · doi:10.1093/qjmed/hcac210 · Cited by 8
Nanomedicine’s transformative impact on anti-diabetic drug discovery: an appraisal
Saini, K., & Sharma, S. (2023) · Journal of Nanoparticle Research · doi:10.1007/s11051-023-05870-8 · Cited by 7
Al‐Najjar, A. H., Khalifa, M. K. A., Amin, O. M., & Badawi, N. M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105745 · Cited by 7
Chauhan, N., Kumar, M., Kumar, K., Chopra, S., & Bhatia, A. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128313325240513113840 · Cited by 7
Stable self-assembled oral metformin-bridged nanocochleates against hepatocellular carcinoma
El-Melegy, M. G., El-Kamel, A. H., Mehanna, R. A., Gaballah, A. H., & Eltaher, H. M. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01724-5 · Cited by 7
Fingolimod loaded niosomes attenuates sevoflurane induced cognitive impairments
Weng, H., Liu, X., Ren, Y., Li, Y., & Li, X. (2021) · Biomedical Microdevices · doi:10.1007/s10544-021-00603-x · Cited by 7
Nanotechnology: Antidiabetics, Antioxidant and Anti-inflammatory
Samrat, K., Murthy, T. P. K., Divyashri, G., Krishna, R. H., & Chandraprabha, M. N. (2023) · Springer eBooks · doi:10.1007/978-981-99-1635-1_8 · Cited by 6
RECENT ADVANCES IN TREATMENT APPROACHES FOR DIABETES MELLITUS AND RELATED COMPLICATIONS: A REVIEW
Dhyani, S., Butola, M., Sautha, V., & Jakhmola, V. (2025) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2025v17i2.53184 · Cited by 6
Potential Nanomaterials for the Treatment and Management of Diabetes Mellitus
Tiwari, S. S., & Wadher, S. J. (2023) · Springer eBooks · doi:10.1007/978-981-99-1635-1_11 · Cited by 5
Amin, N. A. B. M., Hussen, R. S. D., Lee, S. M., Sim, K. S., & Navanesan, S. (2019) · Main Group Metal Chemistry · doi:10.1515/mgmc-2019-0010 · Cited by 5
Pan, Q., Chen, C., & Yang, Y. (2023) · Current Medical Science · doi:10.1007/s11596-023-2818-2 · Cited by 4
The Impact of Hyaluronic Acid Coating on the Cationic Niosomal Surface for Doxorubicin Delivery
Mazzotta, E., Romeo, M., Sacco, G., Benedittis, S. D., Qualtieri, A., Perrotta, I. D., & Muzzalupo, R. (2025) · Molecules · doi:10.3390/molecules30051148 · Cited by 3
Pinheiro, T. M., Almeida, T. C. D. A., Silva, J. D. O., Lopes, J. L., Cassali, G. D., Melo, M. M., Lempek, M. R., Ferreira, R. D. S., Townsend, D. M., Leite, E. A., et al. (2025) · ACS Omega · doi:10.1021/acsomega.5c08220 · Cited by 3
Chettupalli, A. K., Bukke, S. P. N., Rahaman, S. A., Bodige, M., Kanakaraju, V. K., Kavitha, M., Srinivasarao, D., Mohammed, A., Goruntla, N., & Yadesa, T. M. (2025) · BMC Biotechnology · doi:10.1186/s12896-025-01069-y · Cited by 3
Formulation and evaluation of sustained release tablets of propranolol hydrochloride
Purohit, D., Gupta, M. K., Meher, C. P., Shukla, A., & Kumar, A. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns1.6287 · Cited by 3
Kenechukwu, F. C., Nnamani, D. O., Nmesirionye, B. U., Isaac, G. T., Momoh, M. A., & Attama, A. A. (2022) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-022-09654-w · Cited by 3
An evaluation of the effects of ethosomes in the delivery of transdermal drugs
Gad, S., mousa, I., Hammady, T. M., & sayed, O. (2022) · Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences · doi:10.21608/rpbs.2022.141371.1147 · Cited by 3
Javidan, A. N., Samadi, F. Y., Latifi, S., Jafari‐Nodoushan, M., & Mobedi, H. (2014) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(14)50082-2 · Cited by 3
Bhardwaj, A., Verma, S., Agnihotri, A., & Chitme, H. R. (2025) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2025.2548844 · Cited by 2
Ghoraba, H., Ashrafi, F., Nadushan, R. M., & Abbaspour, H. (2026) · BMC Biotechnology · doi:10.1186/s12896-026-01132-2 · Cited by 2
Metadata
- Authors
- Hasan, A. A., Madkor, H., & Wageh, S.
- Affiliations
- Zagazig University (EG)
- Al-Azhar University (EG)
- Corresponding author
- Hasan, Azza A.
- ORCID
- Madkor, Hafez
- Venue
- Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2013-04
- Volume
- 20
- Issue
- 3-4
- Pages
- 120-126
- ISSN
- 1071-7544 (ISSN-L)
- 1521-0464
- OpenAlex
- W2163002418
- Cited by
- 122
- References
- 39
- Citations by year
- 2026: 3 · 2025: 17 · 2024: 7 · 2023: 16 · 2022: 16 · 2021: 8 · 2020: 12 · 2019: 12 · 2018: 8 · 2017: 9 · 2016: 4 · 2015: 7 · 2014: 3
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Drug Delivery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- metformin hydrochloride, niosomes, controlled release, oral drug delivery, bioavailability, diabetes mellitus, lactic acidosis, DOTAP, dicetyl phosphate, encapsulation efficiency, hypoglycemic effect, pharmacokinetics, Span 40, cholesterol
- MeSH terms
- Animals, Blood Glucose, Chemistry, Pharmaceutical, Delayed-Action Preparations, Drug Evaluation, Preclinical, Liposomes, Male, Metformin, Random Allocation, Drug Delivery Systems, Rats, Wistar, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review